Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « Pays » - entrée « Niger »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mexique < Niger < Norvège  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
001D60 (2016) Diego Coronel ; Ana Armesto ; Secundino Cigarrán ; Jesus Calvi O [Espagne, Niger]Legionella Pneumophila: A Renal Vasculitis Trigger?
001D69 (2016) Thomas Green [Royaume-Uni] ; Jonathan Hind [Royaume-Uni, Niger]Graft‐versus‐host disease in paediatric solid organ transplantation: A review of the literature
001D87 (2016) Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study
002186 (2015) Shiue-Wei Lai [Taïwan] ; Tzu-Chuan Huang [Taïwan] ; Ren-Hua Ye [Taïwan] ; Yi-Ying Wu [Taïwan, Niger]Necrotizing fasciitis in two patients with myelodysplastic syndrome treated with azacitidine
002C49 (2013) Marvin Rubenstein [États-Unis, Niger] ; Courtney M. P. Hollowell [États-Unis] ; Patrick Guinan [États-Unis]Oligonucleotide suppression of bcl-2 in LNCaP cells is compensated by increased androgen sensitivity, p53 and oncogene activity, and suppressed caspase-3
002F53 (2013) Yao Yao [République populaire de Chine] ; Cong-Zhu Ding [République populaire de Chine] ; Yun Fang [République populaire de Chine, Niger]Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats
003346 (2013) Lydia Bresolin [Australie, Niger]A mother describes her child's experience with juvenile arthritis
003660 (2012) Anshuman P. Malaviya [Royaume-Uni, Niger] ; Andrew J. K. Östör [Royaume-Uni]Rheumatoid arthritis and the era of biologic therapy
003691 (2012) D R Mould [États-Unis, Niger]Model‐Based Meta‐Analysis: An Important Tool for Making Quantitative Decisions During Drug Development
003740 (2012) D L Scott [Royaume-Uni, Niger]Biologics‐Based Therapy for the Treatment of Rheumatoid Arthritis
003751 (2012) Raffaele Strippoli [Italie] ; Francesco Carvello [Italie] ; Roberta Scianaro [Italie] ; Loredana De Pasquale [Italie] ; Marina Vivarelli [Italie] ; Stefania Petrini [Italie] ; Luisa Bracci-Laudiero [Italie] ; Fabrizio De Benedetti [Italie, Niger]Amplification of the response to Toll‐like receptor ligands by prolonged exposure to interleukin‐6 in mice: Implication for the pathogenesis of macrophage activation syndrome
003A79 (2011) Richard Charles John Campbell [Royaume-Uni, Niger] ; Michael Batley [Royaume-Uni] ; Anthony Hammond [Royaume-Uni] ; Fowzia Ibrahim [Royaume-Uni] ; Gabrielle Kingsley [Royaume-Uni] ; David L. Scott [Royaume-Uni]The impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis
003B85 (2011) S. Graf [Allemagne, Niger] ; P.-M. Schumm-Draeger [Allemagne]Diabetes und Rheuma
004032 (2009) Ainara Rodriguez-Marco [Royaume-Uni] ; Mark Bradbury [Royaume-Uni] ; Philip Riley [Royaume-Uni] ; Peter D. Arkwright [Royaume-Uni, Niger]Autoimmunity and recurrent infections in partial complement C3 immunodeficiency
004048 (2009) Tong Li [République populaire de Chine] ; Xiaoxia Zuo [République populaire de Chine] ; Yaou Zhou [République populaire de Chine] ; Yanping Wang [République populaire de Chine] ; Hanping Zhuang [République populaire de Chine] ; Lingli Zhang [République populaire de Chine] ; Huali Zhang [République populaire de Chine] ; Xianzhong Xiao [République populaire de Chine, Niger]The Vagus Nerve and Nicotinic Receptors Involve Inhibition of HMGB1 Release and Early Pro-inflammatory Cytokines Function in Collagen-Induced Arthritis
004102 (2009) E. Wipfler-Frei Muth [Autriche, Niger] ; J. Loock ; F. Moosig ; C. Dejaco [Autriche] ; C. Duftner [Autriche] ; M. Schirmer [Autriche]Aktuelle Therapieansätze bei Riesenzellarteriitis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/AffPays.i -k "Niger" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/AffPays.i  \
                -Sk "Niger" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Niger
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021